Sarah Perreault

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Maximilian Stahl, Michelle DeVeaux, Pau Montesinos et al. · Blood Advances · 2018 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The use of basiliximab–infliximab combination for the treatment of severe gastrointestinal acute GvHD

Michelle Nadeau, Sarah Perreault, Stuart Seropian et al. · Bone Marrow Transplantation · 2015 · 26 citations

Medicine, Pharmacotherapy, Gastroenterology +1

Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas

Iris Isufi, Stuart Seropian, Lohith Gowda et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 25 citations

Medicine, Immunology, Oncology +14

Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion

Sarah Perreault, Molly Schiffer, Virginia Clinchy-Jarmoszko et al. · American Journal of Health-System Pharmacy · 2021 · 23 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies

Sarah Perreault, Dayna McManus, Anthony D. Anderson et al. · Journal of Oncology Pharmacy Practice · 2018 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +17